Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries

NCT03944473 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Stopped before IRB approval

Conditions

Ambulatory Difficulty

Interventions

DRUG: Sugammadex
DRUG: Neostigmine

Sponsor

Montefiore Medical Center